Holdings
Knott David M Jr
As of Jun 30, 2026, Knott David M Jr reported 72 positions worth US$168M. Largest: Alphabet Inc (google) Class C, Apollo Global Management, Inc. (new) and Syndax Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Alphabet Inc (google) Class C | 90,687 | US$32.4M | −811 | Jun 30, 2026 |
| Apollo Global Management, Inc. (new) | 225K | US$26.6M | no change | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 437K | US$9.56M | +15,245 | Jun 30, 2026 |
| Xeris Biopharma Holdings, Inc. | 1.06M | US$8.4M | no change | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 147K | US$8.37M | +6,649 | Jun 30, 2026 |
| Protagonist Therapeutics, Inc. | 63,000 | US$7.72M | no change | Jun 30, 2026 |
| Bridgebio Pharma, Inc. | 92,850 | US$6.92M | +2,850 | Jun 30, 2026 |
| Iovance Biotherapeutics, Inc. | 1.6M | US$6.66M | no change | Jun 30, 2026 |
| Jp Morgan Chase & Co. | 18,098 | US$5.92M | −1,379 | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 111K | US$4.3M | +7,081 | Jun 30, 2026 |